Every year there are an estimated 500,000 new cases of visceral leishmaniasis (VL) and more than 50,000 deaths from the disease, a death toll that is surpassed among the parasitic diseases only by malaria. The epidemiology, clinical presentation and pathogenesis of VL are reviewed, along with the current control strategies and research challenges.
- François Chappuis
- Shyam Sundar
- Marleen Boelaert
